To Get Help Now
Click Here
 
Today's Date:

With Mediation, Glaxo Settles Nearly 25,000 Avandia Lawsuits

AddThis Social Bookmark Button

A special mediator assigned by U.S. District Judge Cynthia Rufe to head settlement negotiations in GlaxoSmithKline (GSK) multidistrict litigation over the diabetes drug Avandia has helped the company settle nearly 25,000 lawsuits. Jude Rufe called their work a “major success,” and said that “Mediation will no longer be the focus of this court’s effort….we will resolve the remaining cases through litigation.”

Rufe is presiding over the consolidation of more than 2,500 cases, which does not include lawsuits filed in state courts across the country. Currently, GSK has resolved nearly 50,000 cases across both the state and federal courts. About the remaining lawsuits, Rufe said, “From what I’m hearing today, there aren’t a lot of cases left to be tried, and not all those cases will make it to trial,” Bloomberg reported.

GSK earlier agreed to pay over $700 million to settle 15,000 patient claims that Avandia caused stroke and heart attack. In 2010, the drug company stop marketing Avandia worldwide after the link between the drug and an increased risk of heart attack was reported.

breakinglawsuitnews.com disclaimer: This article: With Mediation, Glaxo Settles Nearly 25,000 Avandia Lawsuits was posted on Wednesday, February 15th, 2012 at 8:26 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Comments are closed.